Evidence map›Paper›PMID 35685241›Full record

ArticleFrontiers in molecular biosciences2022

A New Strategy for High-Efficient Tandem Enrichment and Simultaneous Profiling of N-Glycopeptides and Phosphopeptides in Lung Cancer Tissue.

Zhuokun Du, Qianying Yang, Yuanyuan Liu, Sijie Chen, Hongxian Zhao, Haihong Bai, Wei Shao, Yangjun Zhang, Weijie Qin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Zhuokun DuSchool of Basic Medical Science, Anhui Medical University, Hefei, China.
Qianying YangSchool of Basic Medical Science, Anhui Medical University, Hefei, China.
Yuanyuan LiuState Key Laboratory of Proteomics, National Center for Protein Sciences Beijing, Beijing Institute of Lifeomics, Beijing Proteome Research Center, Beijing, China.
Sijie ChenSchool of Basic Medical Science, Anhui Medical University, Hefei, China.
Hongxian ZhaoState Key Laboratory of Proteomics, National Center for Protein Sciences Beijing, Beijing Institute of Lifeomics, Beijing Proteome Research Center, Beijing, China.
Haihong BaiPhase I Clinical Trial Center, Beijing Shijitan Hospital of Capital Medical University, Beijing, China.
Wei ShaoSchool of Basic Medical Science, Anhui Medical University, Hefei, China.
Yangjun ZhangSchool of Basic Medical Science, Anhui Medical University, Hefei, China.
Weijie QinSchool of Basic Medical Science, Anhui Medical University, Hefei, China.
Anhui Medical University · CNBeijing Proteome Research Center · CNBeijing Shijitan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

N-glycosylation and phosphorylation, two common posttranslational modifications, play important roles in various biological processes and are extensively studied for biomarker and drug target screening. Because of their low abundance, enrichment of N-glycopeptides and phosphopeptides prior to LC-MS/MS analysis is essential. However, simultaneous characterization of these two types of posttranslational modifications in complex biological samples is still challenging, especially for tiny amount of samples obtained in tissue biopsy. Here, we introduced a new strategy for the highly efficient tandem enrichment of N-glycopeptides and phosphopeptides using HILIC and TiO

Indexed as

enrichmentmass spectrometryN-glycopeptidesphosphopeptidesproteomics

Identifiers

PMID35685241
PMCPMC9171396
OpenAlexW4281394591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.